Concepedia

Ons Harrabi

OH

Statistics

Publications

11

Citations

722

H-Index

11

Active since

2003

Affiliations

University of California, San Francisco(Current)

Pfizer (United States)

Collaborative Drug Discovery (United States)

Ons Harrabi is an author at University of California, San Francisco specializing in medicine, molecular biology, and cell biology.

Top concepts

Publications per year

2003–2021

11

Publications

11

Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration

Jindong Ding, Lincoln V. Johnson, Rolf Herrmann et al. · Proceedings of the National Academy of Sciences · 2011 · 187 citations · Full text

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

Steven E. Kauder, Tracy C. Kuo, Ons Harrabi et al. · PLoS ONE · 2018 · 164 citations · Full text

, , +18

Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease

Sherry L. La Porte, Sangeetha Bollini, Thomas A. Lanz et al. · Journal of Molecular Biology · 2011 · 94 citations

, , +7

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

Tracy C. Kuo, Amy Chen, Ons Harrabi et al. · Journal of Hematology & Oncology · 2020 · 69 citations · Full text

Viral regulation of the long distance axonal transport of herpes simplex virus nucleocapsid

Jennifer H. LaVail, Andrew N. Tauscher, Anatol Sucher et al. · Neuroscience · 2007 · 56 citations · Full text

, , +8

1–5 of 11